SCIENTIFIC ADVISORY COUNCIL AGREEMENTScientific Advisory Council Agreement • October 10th, 2017 • Ultragenyx Pharmaceutical Inc. • Pharmaceutical preparations • Massachusetts
This Scientific Advisory Council Agreement, effective 1/6/2015 (this “Agreement”) amends and restates in its entirety that certain Advisory Board Agreement dated October 1, 2013 by and between Dimension Therapeutics, Inc., a Delaware corporation, with a place of business at 840 Memorial Drive, Cambridge, MA 02139, USA (the “Company”) and Emil Kakkis, an individual (the “Advisor”) (the “Prior Agreement”). From and after the effective date of this Agreement, the services performed by Advisor under the Prior Agreement will be deemed to have been performed under this Agreement and the Prior Agreement shall have no further force and effect.
